NIOX Group PLC
82C
Company Profile
Business description
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, theĀ United States, the United Kingdom, and the Rest of the world.
Contact
Edmund Halley Road
Hayakawa Building
The Oxford Science Park
OxfordOX4 4GB
GBRT: +44 3303309356
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
92
Stocks News & Analysis
stocks
Unconventional wisdom: A controversial income pick
Rigid definitions of income and growth shares may be holding investors back.
stocks
How to avoid dividend disaster
Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,780.30 | 4.80 | -0.05% |
CAC 40 | 7,973.03 | 34.59 | -0.43% |
DAX 40 | 21,787.00 | 115.42 | -0.53% |
Dow JONES (US) | 44,303.40 | 444.23 | -0.99% |
FTSE 100 | 8,700.53 | 26.75 | -0.31% |
HKSE | 21,133.54 | 241.92 | 1.16% |
NASDAQ | 19,523.40 | 268.59 | -1.36% |
Nikkei 225 | 38,787.02 | 279.51 | -0.72% |
NZX 50 Index | 12,902.19 | 57.60 | 0.45% |
S&P 500 | 6,025.99 | 57.58 | -0.95% |
S&P/ASX 200 | 8,511.40 | 9.30 | -0.11% |
SSE Composite Index | 3,303.67 | 33.01 | 1.01% |